Evolutionary Genomics: Funding, Investors & Team (Oct 2026)
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
Evolutionary Genomics has raised $1.0M across 1 funding round on record, the most recent a Post-IPO Equity of $1.0M announced in May 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evolutionary Genomics Company Profile and Key Stats
Latest funding round on record: May 2022.
Evolutionary Genomics Funding Rounds
Evolutionary Genomics Founders and Leadership Team
Contact details for the Evolutionary Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Evolutionary Genomics Funding Compared to Other Biotechnology Startups
Evolutionary Genomics' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evolutionary Genomics in Biotechnology and Lafayette
Companies Similar to Evolutionary Genomics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Evolutionary Genomics Funding FAQs
What does Evolutionary Genomics do?
Evolutionary Genomics (EG) is a unique biotechnology company that is changing how relevant gene/target discovery and validation is performed during the post-genomics era. The company's proprietary Adapted Traits platform sifts through vast amounts of genomic data to identify only those genes that have a high likelihood of commercial value for downstream validation. EG applies this platform to identify high-value targets for drug-discovery or genes for use in natural crop yield or pest/disease-resistance enhancement.
How much funding has Evolutionary Genomics raised?
Evolutionary Genomics has raised $1.0M across 1 round on record. The most recent is a Post-IPO Equity of $1.0M announced in May 2022.
When did Evolutionary Genomics last raise funding?
Evolutionary Genomics' most recent funding round on record is a Post-IPO Equity of $1.0M, announced in May 2022.
Who is the CEO of Evolutionary Genomics?
Steve Warnecke is listed as CEO at Evolutionary Genomics.
Where is Evolutionary Genomics headquartered?
Evolutionary Genomics is based in Lafayette, Colorado, United States.
How many employees does Evolutionary Genomics have?
Evolutionary Genomics is in the 1-10 employee band.
How does Evolutionary Genomics' funding compare to other Biotechnology startups?
Evolutionary Genomics' latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Evolutionary Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evolutionary Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.